Lung cancer associated autoantibody responses are detectable years before clinical presentation.
The EarlyCDT-Lung® test detects elevated levels of tumour-associated autoantibodies generated in response to immune recognition of cancerous cells, and these autoantibodies have previously been shown to precede clinical presentation of lung cancer. Using a longitudinal cohort from the United Kingdom...
Saved in:
| Main Authors: | Jared Allen, Graham Healey, Isabel Macdonald |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315220 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung cancer associated autoantibody responses are detectable years before clinical presentation
by: Jared Allen, et al.
Published: (2025-01-01) -
Exosome autoantibody biomarkers for detection of lung cancer
by: Win Lwin Thuya, et al.
Published: (2024-11-01) -
BARD1 serum autoantibodies for the detection of lung cancer.
by: Maxim Pilyugin, et al.
Published: (2017-01-01) -
Human Blood Autoantibodies in the Detection of Colorectal Cancer.
by: Ola H Negm, et al.
Published: (2016-01-01) -
Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer
by: Ying Ye, et al.
Published: (2025-01-01)